Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 49,150 shares at $104.92 ($4.2M) on 2022-08-15, disclosed to the SEC on 2022-08-15.
Seasonal sale ($4.2M) by Chairman & CEO — this insider has traded EW in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $104.03 | 4,002 | $416K | 10.0% |
| 3 | $104.03 | 4,002 | $416K | 10.0% |
| 4 | $104.92 | 15,773 | $1.7M | 39.8% |
| 5 | $104.92 | 15,773 | $1.7M | 39.8% |
| 6 | $105.41 | 100 |
| $11K |
| 0.3% |
| Total | $84.50 avg | 49,150 | $4.2M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |